TOBACCO REGULATION BEING CONSIDERED BY FDA

被引：0

|

作者：

MCCARTHY, M

机构：

来源：

LANCET | 1994年 / 343卷 / 8898期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：664 / 664

页数：1

相关论文

共 50 条

[31] Tobacco, Public Health, and the FDA
Curfman, Gregory D.
Morrissey, Stephen
Drazen, Jeffrey M.
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (04): : 402 - 403
[32] FDA leery of tobacco oversight
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (18): : 2129 - 2129
[33] FDA getting tough with tobacco
不详
PIMA MAGAZINE, 1996, 78 (06): : 23 - 23
[34] The Tobacco Control Act and the FDA Center for Tobacco Products
Koenig, Michael
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[35] Revlimid® being considered for use in the NHS
不详
IMMUNOTHERAPY, 2009, 1 (02) : 168 - 168
[36] PREVENTION TRIAL WITH TAMOXIFEN BEING CONSIDERED
SMIGEL, K
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (22) : 1737 - 1738
[37] NIH, FDA Setting Up Research Centers to Generate Evidence Base to Inform Tobacco Regulation
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (15): : 1550 - 1550
[38] FDA Tobacco Product Regulations: A Powerful Tool for Tobacco Control
Deyton, Lawrence R.
PUBLIC HEALTH REPORTS, 2011, 126 (02) : 167 - 169
[39] FDA, NIH TO CREATE TOBACCO CENTERS
不详
CHEMICAL & ENGINEERING NEWS, 2013, 91 (39) : 23 - 23
[40] The FDA's struggle to regulate tobacco
Costello, J
ADMINISTRATIVE LAW REVIEW, 1997, 49 (03) : 671 - 689

← 1 2 3 4 5 →